These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 29332704)

  • 21. Cutaneous Squamous Cell Carcinoma.
    Waldman A; Schmults C
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):1-12. PubMed ID: 30497667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low incidence of metastasis and recurrence from cutaneous squamous cell carcinoma found in a UK population: Do we need to adjust our thinking on this rare but potentially fatal event?
    Nelson TG; Ashton RE
    J Surg Oncol; 2017 Nov; 116(6):783-788. PubMed ID: 28703911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
    Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
    Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Value of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Based on the AJCC-8 and Brigham and Women's Hospital Staging Criteria.
    Tejera-Vaquerizo A; Cañueto J; Llombart B; Martorell-Calatayud A; Sanmartín O
    Dermatol Surg; 2020 Jul; 46(7):857-862. PubMed ID: 31567487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staging cutaneous squamous cell carcinoma metastases to the parotid gland.
    Czerwonka L; De Santis RJ; Horowitz G; Hong M; Orsini M; Enepekides D; Goldstein DP; Dort J; Higgins K
    Laryngoscope; 2017 Sep; 127(9):2063-2069. PubMed ID: 28295401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tracking the risk factors associated with high-risk cSCC: A 10-year, Two-Institution, Greek study.
    Dimonitsas E; Champsas G; Kakagia D; Stavrianos S; Roussos S; Doryforou O; Neamonitou F; Soura E; Kostopoulos E; Christofidou E; Papadopulos O; Thymara I; Papadopulos NA; Stratigos A; Korkolopoulou P
    J BUON; 2021; 26(3):1148-1158. PubMed ID: 34268983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma.
    Wysong A; Newman JG; Covington KR; Kurley SJ; Ibrahim SF; Farberg AS; Bar A; Cleaver NJ; Somani AK; Panther D; Brodland DG; Zitelli J; Toyohara J; Maher IA; Xia Y; Bibee K; Griego R; Rigel DS; Meldi Plasseraud K; Estrada S; Sholl LM; Johnson C; Cook RW; Schmults CD; Arron ST
    J Am Acad Dermatol; 2021 Feb; 84(2):361-369. PubMed ID: 32344066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.
    Thompson AK; Kelley BF; Prokop LJ; Murad MH; Baum CL
    JAMA Dermatol; 2016 Apr; 152(4):419-28. PubMed ID: 26762219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system.
    Dinehart SM; Peterson S
    Dermatol Surg; 2005 Nov; 31(11 Pt 1):1379-84. PubMed ID: 16416604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
    Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
    JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
    Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
    J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma.
    Krediet JT; Beyer M; Lenz K; Ulrich C; Lange-Asschenfeldt B; Stockfleth E; Terhorst D
    Br J Dermatol; 2015 Apr; 172(4):1029-36. PubMed ID: 25362868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
    Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
    J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines of care for the management of cutaneous squamous cell carcinoma.
    ; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olenecki T; Rodgers P
    J Am Acad Dermatol; 2018 Mar; 78(3):560-578. PubMed ID: 29331386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.
    Metchnikoff C; Mully T; Singer JP; Golden JA; Arron ST
    J Am Acad Dermatol; 2012 Nov; 67(5):829-35. PubMed ID: 22285618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
    Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
    Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.
    Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA
    JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
    Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
    JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of advanced cutaneous squamous cell carcinoma.
    Dessinioti C; Pitoulias M; Stratigos AJ
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):39-50. PubMed ID: 34592000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.